Ribozyme-mediated selective killing of cancer cells expressing carcinoembryonic antigen RNA by targeted trans-splicing

Biochemical and Biophysical Research Communications

Volumn 349, Issue 2, 2006, Pages 556-563

  Jung, Heung Su ^a   Lee, Seong Wook ^a  

^a Dankook University   (South Korea)

Author keywords

Cancer gene therapy; Carcinoembryonic antigen; Group I intron; RNA replacement; Trans splicing ribozyme

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GANCICLOVIR; RIBOZYME; RNA; THYMIDINE KINASE;

ACCURACY; APOPTOSIS; ARTICLE; CANCER CELL; CELL ADHESION; CELL KILLING; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENE THERAPY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; RNA SPLICING; SUICIDE GENE; TRANSGENE;

ALTERNATIVE SPLICING; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION; CELL LINE, TUMOR; GENE THERAPY; HUMANS; INTRONS; NEOPLASM METASTASIS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, CATALYTIC; SENSITIVITY AND SPECIFICITY; TRANSGENES;

SIMPLEXVIRUS;

EID: 33748433235     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.08.073     Document Type: Article

References (34)

1. Goldenberg D.M., Sharkey R.M., and Primus F.J. Carcinoembryonic antigen in histopathology: immunoperoxidase staining of conventional tissue sections. J. Natl. Cancer Inst. 57 (1976) 11-22
2. Shively J.E., and Beatty J.D. CEA-related antigens: molecular biology and clinical significance. Crit. Rev. Oncol. Hematol. 2 (1985) 355-399
3. Thompson J.A., Grunert F., and Zimmermann W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5 (1991) 344-366
4. Gold P., and Goldenberg N.A. The carcinoembryonic antigen (CEA): past, present, and future. McGill J. Med. 3 (1997) 46-66
5. Hammarstrom S., Olsen A., Teglund S., and Baranov V. The nature and expression of the human CEA family. In: Stanners C.P. (Ed). Cell Adhesion and Communications Mediated by the CEA Family vol. 5 (1998), Harwood Academic, Amsterdam 1-30
6. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9 (1999) 67-81
7. Keesee S.K., Briggman J.V., Thill G., and Wu Y.J. Utilization of nuclear matrix proteins for cancer diagnosis. Crit. Rev. Eukaryot. Gene Exp. 6 (1996) 189-214
8. Bast Jr. R.C., Ravdin P., Hayes D.F., Bates S., Fritsche Jr. H., Jessup J.M., Kemeny N., Locker G.Y., Mennel R.G., and Somerfield M.R. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19 (2001) 1865-1878
9. Khare D., Shao-Xi L., Kuroki M., Hirose Y., Arakawa F., Nakamura K., Tomita Y., and Kuroki M. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase. Cancer Res. 61 (2001) 370-375
10. Benchimol S., Fuks A., Jothy S., Beauchemin N., Shirota K., and Stanners C.P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57 (1989) 327-334
11. Stanners C.P., and Fuks A. Properties of adhesion mediated by the human CEA family. In: Stanners C.P. (Ed). Cell Adhesion and Communications Mediated by the CEA Family vol. 5 (1998), Harwood Academic, Amsterdam 57-72
12. Jessup J.M., and Thomas P. CEA and metastasis: a facilitator of site-specific metastasis. In: Stanners C.P. (Ed). Cell Adhesion and Communications Mediated by the CEA Family vol. 5 (1998), Harwood Academic, Amsterdam 195-222
13. Von Kleist S., Migule I., and Halla B. Possible function of CEA as cell-contact inhibitory molecule. Anticancer Res. 15 (1995) 1889-1894
14. Hostetter R.B., Augustus L.B., Mankarious R., Chi K., Fan D., Toth C., Thomas P., and Jessup J.M. Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. J. Natl. Cancer Inst. 82 (1990) 380-385
15. Hashino J., Fukuda Y., Oikawa S., Nakazato H., and Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin. Exp. Metastasis 12 (1994) 324-328
16. Leconte A., Garambois V., Ychou M., Robert B., Pourquier D., Terskikh A., Mach J.P., and Pelegrin A. Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model. Br. J. Cancer 80 (1999) 1373-1379
17. Kammerer R., and von Klieist S. The carcinoembryonic antigen (CEA) modulates effector-target cell interaction by binding to activated lymphocytes. Int. J. Cancer 68 (1996) 457-463
18. Ordonez C., Screaton R.A., Ilantzis C., and Stanners C.P. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 60 (2000) 3419-3424
19. Sullenger B.A., and Cech T.R. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317 (1994) 619-622
20. Jones J.T., Lee S.W., and Sullenger B.A. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2 (1996) 643-648
21. Sullenger B.A. Revising messages traveling along the cellular information superhighway. Curr. Biol. 2 (1995) 249-253
22. Lan N., Howrey R.P., Lee S.W., Smith C.A., and Sullenger B.A. Ribozyme-mediated repair of sickle β-globin mRNAs in erythrocyte precursors. Science 280 (1998) 1593-1596
23. Phylactou L.A., Darrah C., and Wood M.A.J. Ribozyme mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18 (1998) 378-381
24. Rogers C.S., Vanoye C.G., Sullenger B.A., and George Jr. A.L. Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J. Clin. Invest. 110 (2002) 1783-1798
25. Shin K.S., Sullenger B.A., and Lee S.W. Ribozyme-mediated induction of apoptosis in human cancer cells by targeted repair of mutant p53 RNA. Mol. Ther. 10 (2004) 365-372
26. Kastanos E., Hjiantoniou E., and Phylactou L.A. Restoration of protein synthesis in pancreatic cancer cells by trans-splicing ribozymes. Biochem. Biophys. Res. Commun. 322 (2004) 930-934
27. Ryu K.J., Kim J.H., and Lee S.W. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7 (2003) 386-395
28. Byun J., Lan N., Long M., and Sullenger B.A. Efficient and specific repair of sickle β-globin RNA by trans-splicing ribozymes. RNA 9 (2003) 1254-1263
29. Kohler U., Ayre B.G., Goodman H.M., and Haseloff J. Trans-splicing ribozymes for targeted gene delivery. J. Mol. Biol. 185 (1999) 1935-1950
30. Kwon B.S., Jung H.S., Song M.S., Cho K.S., Kim S.C., Kimm K., Jeong J.S., Kim I.H., and Lee S.W. Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol. Ther. 12 (2005) 824-834
31. Matthews T., and Boehme R. Antiviral activity and mechanism of action of ganciclovir. Rev. Infect. Dis. 10 (1988) S490-S494
32. Wirth T., Soeth E., Czubayko F., and Juhl H. Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growth. Clin. Exp. Metastasis 19 (2002) 155-160
33. 131I-labeled monoclonal antibodies. Cancer Res. 52 (1992) 6036-6044
34. Blumenthal R.D., Hansen H.J., and Goldenberg D.M. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 carcinoembryonic antigen. Cancer Res. 65 (2005) 8809-8817